Diversis Capital buys Caligor Rx

Diversis Capital LLC said April 8 that it has acquired a majority of Caligor Rx Inc. Financial terms weren’t announced. Secaucus, New Jersey-based Caligor delivers strategic clinical trial supply and logistics services to the pharmaceutical and biotechnology industries. Tammy Bishop, previously managing director of Caligor, was named CEO of the Company.

DealsNorth AmericaUSBriefs